156 related articles for article (PubMed ID: 7141061)
21. Atypical cutaneous changes after topical treatment with nitrogen mustard in patients with mycosis fungoides.
Reddy VB; Ramsay D; Garcia JA; Kamino H
Am J Dermatopathol; 1996 Feb; 18(1):19-23. PubMed ID: 8721586
[TBL] [Abstract][Full Text] [Related]
22. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance.
Van Scott EJ; Kalmanson JD
Cancer; 1973 Jul; 32(1):18-30. PubMed ID: 4577503
[No Abstract] [Full Text] [Related]
23. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
Talpur R; Venkatarajan S; Duvic M
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
[TBL] [Abstract][Full Text] [Related]
24. [Topical chemotherapy in mycosis fungoides (author's transl)].
Touraine R; Revuz J
Dermatologica; 1978; 157(6):397-406. PubMed ID: 363476
[No Abstract] [Full Text] [Related]
25. Responses of mycosis fungoides to intensive external treatment with nitrogen mustard.
Van Scott EJ; Winters PL
Arch Dermatol; 1970 Nov; 102(5):507-14. PubMed ID: 5474113
[No Abstract] [Full Text] [Related]
26. Topical nitrogen mustard therapy in patients with mycosis fungoides or parapsoriasis.
Lindahl LM; Fenger-Gron M; Iversen L
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):163-8. PubMed ID: 22229501
[TBL] [Abstract][Full Text] [Related]
27. Frequent low doses of intravenous mechlorethamine for late-stage mycosis fungoides lymphoma.
Van Scott EJ; Grekin DA; Kalmanson JD; Vonderheid EC; Barry WE
Cancer; 1975 Nov; 36(5):1613-8. PubMed ID: 1192353
[TBL] [Abstract][Full Text] [Related]
28. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
Ramsay DL; Parnes RE; Dubin N
Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
[TBL] [Abstract][Full Text] [Related]
29. Long-term topical nitrogen mustard treatment does not induce pulmonary fibrosis in MF patients.
Nielsen M; Rasmussen K; Knudsen N; Thestrup-Pedersen K
Acta Derm Venereol; 1994 Jan; 74(1):70-1. PubMed ID: 7908491
[TBL] [Abstract][Full Text] [Related]
30. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
Chinn DM; Chow S; Kim YH; Hoppe RT
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
[TBL] [Abstract][Full Text] [Related]
31. Concentrations of nitrogen mustard in the air during topical treatment of patients with mycosis fungoides.
Van Vloten WA; Cooijmans AC; Poel J; Meulenbelt J
Br J Dermatol; 1993 Apr; 128(4):404-6. PubMed ID: 8494753
[TBL] [Abstract][Full Text] [Related]
32. Exposure at home to airborne concentrations of nitrogen mustard during topical application for the treatment of mycosis fungoides: a case study.
Snell J; Lillquist DR; Lewis-Younger C; Wallace DO
Dermatology; 2000; 200(2):124-8. PubMed ID: 10773700
[TBL] [Abstract][Full Text] [Related]
33. Complete regressions of mycosis fungoides with topical mechlorethamine hydrochloride.
Van Scott EJ
JAMA; 1972 Nov; 222(9):1172. PubMed ID: 4678061
[No Abstract] [Full Text] [Related]
34. Mycosis fungoides. Topical use of nitrogen mustard in recurrent cases.
Arundell FD; Chan WH
Calif Med; 1968 Dec; 109(6):458-61. PubMed ID: 5724878
[TBL] [Abstract][Full Text] [Related]
35. Topical mechlorethamine therapy for mycosis fungoides. Proposed schedule to overcome drug resistance.
Volden G; Molin L; Thomsen K
Arch Dermatol; 1982 Feb; 118(2):138-9. PubMed ID: 7059219
[No Abstract] [Full Text] [Related]
36. The treatment of mycosis fungoides with ointment-based mechlorethamine.
Price NM; Deneau DG; Hoppe RT
Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680
[TBL] [Abstract][Full Text] [Related]
37. Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.
Liner K; Brown C; McGirt LY
Drug Des Devel Ther; 2018; 12():241-254. PubMed ID: 29440874
[TBL] [Abstract][Full Text] [Related]
38. Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study.
Lindahl LM; Fenger-Grøn M; Iversen L
Br J Dermatol; 2014 Mar; 170(3):699-704. PubMed ID: 24024659
[TBL] [Abstract][Full Text] [Related]
39. Treatment of mycosis fungoides: total-skin electron-beam irradiation vs topical mechlorethamine therapy.
Hamminga B; Noordijk EM; van Vloten WA
Arch Dermatol; 1982 Mar; 118(3):150-3. PubMed ID: 7065660
[TBL] [Abstract][Full Text] [Related]
40. [Mycosis fungoides].
Volden G; Eeg Larsen T
Tidsskr Nor Laegeforen; 1977 Nov; 97(32):1671-5. PubMed ID: 594965
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
